Astellas’ gastric cancer therapy gets the go-ahead from UK regulator
The UK health regulator said it approved Astellas Pharma’s therapy to treat a type of gastric cancer. The monoclonal antibody, which will be marketed under the brand name Vyloy, can recognise certain cancer cells and attach to and destroy them.
POPULAR POSTS
Putin may discuss Ukraine peace deal with Trump
November 22, 2024
Spain’s vice-president Ribera blames floods on climate change
November 22, 2024
Storm lashes northwestern US, killing two people
November 22, 2024
Iceland volcano erupts for tenth time in three years
November 22, 2024
LIVE STREAM